Hemoglobin S

Clinical trials for Hemoglobin S explained in plain language.

Never miss a new study

Get alerted when new Hemoglobin S trials appear

Sign up with your email to follow new studies for Hemoglobin S, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could a common arthritis drug help sickle cell patients?

Disease control Recruiting now

This early-stage trial is testing the safety of fostamatinib, a drug already used for arthritis, in 25 adults with stable sickle cell disease. Participants take the pill twice daily for up to 6 weeks, with close monitoring for side effects. The goal is to see if the drug is safe …

Matched conditions: HEMOGLOBIN S

Phase 1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Hemoglobin S

Get alerted when new Hemoglobin S trials appear

Could a common arthritis drug help sickle cell patients?